{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T09:47:43Z","timestamp":1775728063218,"version":"3.50.1"},"reference-count":76,"publisher":"Informa UK Limited","issue":"8","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2022,5,24]]},"DOI":"10.1080\/14656566.2022.2082284","type":"journal-article","created":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T09:02:51Z","timestamp":1655110971000},"page":"873-884","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":6,"title":["Azacitidine and its role in the upfront treatment of acute myeloid leukemia"],"prefix":"10.1080","volume":"23","author":[{"given":"Omar","family":"Raslan","sequence":"first","affiliation":[{"name":"Department of Oncology, Juravinski Cancer Centre \u2013 Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada"},{"name":"Department of Medicine, Division of Hematology, University of Jeddah, College of Medicine, Jeddah, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0579-6709","authenticated-orcid":false,"given":"Alejandro","family":"Garcia-Horton","sequence":"additional","affiliation":[{"name":"Department of Oncology, Juravinski Cancer Centre \u2013 Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2022,6,13]]},"reference":[{"key":"cit0001","unstructured":"National Cancer Institute. SEER cancer Stat Facts: acute Myeloid Leukemia. [Internet]. 2018. Available from: https:\/\/seer.cancer.gov\/statfacts\/html\/amyl.html on 2018 Jun 12."},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31041-9"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2014.1.14"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020001920"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.10-3-176"},{"key":"cit0006","volume-title":"Dacogen [Summary of product characteristics]","author":"European Medicines Agency","year":"2013"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.2165\/11209430-000000000-00000"},{"key":"cit0008","unstructured":"PubChem [Internet]. Bethesda (MD): National Library of Medicine (US), National Center for Biotechnology Information; 2004. PubChem compound summary for CID 9444, Azacitidine; cited 2021 Nov. 28]. Available from 2021 Nov 28: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound."},{"key":"cit0009","unstructured":"HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use VIDAZA safely and effectively. See full prescribing information for VIDAZA. [cited 2022 Feb 2]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2008\/050794s011lbl.pdf"},{"key":"cit0010","first-page":"2760","volume":"30","author":"Li LH","year":"1970","journal-title":"Cancer Res"},{"key":"cit0011","first-page":"959","volume":"71","author":"Glover AB","year":"1987","journal-title":"Cancer Treat Rep"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1016\/0163-7258(85)90080-4"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(85)90192-8"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-11-382226"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-08-0411"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2017.05.010"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1177\/0091270004271947"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1371"},{"key":"cit0019","unstructured":"USP AHT. Product monograph. Toxicology [Internet]. 2010;1\u201355. [cited 2022 May 20]. Available from: https:\/\/media.celgene.com\/content\/uploads\/sites\/23\/Vidaza-Product_Monograph_-_English_Version.pdf."},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(09)70003-8"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.6.2079"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.23.8329"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-01-621664"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2011.606382"},{"key":"cit0025","unstructured":"National Comprehensive Cancer Network. Acute Myeloid Leukemia (Version 1.2022) [Internet]. cited 2021 Dec 22]. Available from 2021 Dec 22: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/aml.pdf."},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020001779"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-10-879866"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.7"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1038\/nrm3722"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-17-0797"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000937"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30010-X"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2006.10.006"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-13-0609"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3048"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2017.1283032"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2014.910657"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-012-1537-8"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-08-868752"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2012971"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1205332"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-02-0492"},{"key":"cit0043","first-page":"1911","volume":"10","author":"Nakao M","year":"1996","journal-title":"Leukemia"},{"key":"cit0044","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00029.2018"},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2013.1.220"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-01-480228"},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25198"},{"key":"cit0048","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.346"},{"key":"cit0049","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-16-0876"},{"key":"cit0050","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-110976"},{"key":"cit0051","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-145379"},{"key":"cit0052","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.3324\/haematol.2020.263392","volume":"106","author":"Swaminathan M","year":"2021","journal-title":"Haematologica"},{"key":"cit0053","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24072"},{"key":"cit0054","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djq187"},{"key":"cit0055","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2010.11.015"},{"key":"cit0056","doi-asserted-by":"publisher","DOI":"10.1038\/nature10860"},{"key":"cit0057","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.91"},{"key":"cit0058","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0903840"},{"key":"cit0059","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPD7NR2RMNQDVF"},{"key":"cit0060","doi-asserted-by":"crossref","first-page":"4956","DOI":"10.1158\/1538-7445.AM2018-4956","volume":"78","author":"Yen K","year":"2018","journal-title":"Cancer Res"},{"key":"cit0061","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.01632"},{"key":"cit0062","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-147805"},{"key":"cit0063","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-04-779405"},{"key":"cit0064","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-019-0472-2"},{"key":"cit0065","unstructured":"Bristol myers squibb provides update on phase 3 IDHENTIFY trial in patients with relapsed or refractory acute myeloid leukemia."},{"key":"cit0066","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-130362"},{"key":"cit0067","unstructured":"DiNardo C, Schuh A, Stein E, et al. enasidenib plus azacitidine significantly improves complete remission and overall response rates versus azacitidine monotherapy in mutant-IDH2 newly diagnosed acute myeloid leukemia (nd-aml). 2020. [cited 2022 Feb 2]. Available from: https:\/\/library.ehaweb.org\/eha\/2020\/eha25th\/294959\/courtney.dinardo.enasidenib.plus.azacitidine.significantly.improves.complete.html?f=listing%3D3%2Abrowseby%3D8%2Asortby%3D1%2Amedia%3D1."},{"key":"cit0068","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00494-0"},{"key":"cit0069","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0135520"},{"key":"cit0070","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2004444"},{"key":"cit0071","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.06.016"},{"key":"cit0072","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2014.03.004"},{"key":"cit0073","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1600-0609.2010.01456.x","volume":"85","author":"Santini V","year":"2010","journal-title":"Eur J Haematol"},{"key":"cit0074","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S3143"},{"key":"cit0075","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-153571"},{"key":"cit0076","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-153638"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2022.2082284","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T01:06:19Z","timestamp":1700701579000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14656566.2022.2082284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,24]]},"references-count":76,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,5,24]]}},"alternative-id":["10.1080\/14656566.2022.2082284"],"URL":"https:\/\/doi.org\/10.1080\/14656566.2022.2082284","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,24]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-02-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}